lipitor rashes
Overview of Efficacy Results in TNT Endpoint lipitor rashes 10 mg (N=5006) Atorvastatin 80 mg (N=4995) HR* (95%CI) PRIMARY ENDPOINT n (%) n (%) First major cardiovascular endpoint 548 (10.9) 434 (8.7) 0.78 (0.69, 0.89) Components of the Primary Endpoint CHD death 127 (2.5) 101 (2.0) 0.80 (0.61, 1.03) Non-fatal, non-procedure related MI 308 (6.2) 243 lipitor rashes 0.78 (0.66, 0.93) Resuscitated cardiac arrest 26 (0.5) 25 (0.5) 0.96 (0.56, 1.67) Stroke (fatal and non-fatal) 155 (3.1) 117 (2.3) 0.75 (0.59, 0.96) SECONDARY ENDPOINTS† First CHF with hospitalization 164 (3.3) 122 (2.4) 0.74 (0.59, 0.94) First PVD endpoint 282 (5.6) lipitor rashes (5.5) 0.97 (0.83, 1.15) lipitor rashes CABG or other coronary revascularization procedure‡ 904 (18.1) lipitor rashes (13.4) 0.72 (0.65, 0.80) First documented angina endpoint‡ 615 (12.3) 545 (10.9) 0.88 (0.79, 0.99) All-cause mortality 282 (5.6) 284 (5.7) 1.01 (0.85, 1.19) Components of All-Cause Mortality lipitor rashes Cardiovascular lipitor rashes 155 (3.1) 126 (2.5) 0.81 (0.64, 1.03) Noncardiovascular death 127 (2.5) lipitor rashes (3.2) 1.25 (0.99, 1.57) Cancer death 75 (1.5) 85 (1.7) 1.13 (0.83, 1.55) Other non-CV death 43 (0.9) 58 (1.2) 1.35 (0.91, 2.00) Suicide, homicide, and other traumatic non-CV death 9 (0.2) 15 (0.3) 1.67 (0.73, 3.82) HR=hazard ratio; CHD=coronary heart disease; CI=confidence interval; MI=myocardial infarction; CHF=congestive heart failure; CV=cardiovascular; PVD=peripheral vascular disease; CABG=coronary artery bypass graft Confidence intervals for the Secondary Endpoints were not adjusted for multiple comparisons * Atorvastatin 80 mg; atorvastatin 10 mg † Secondary endpoints not included in primary endpoint ‡ Component of other secondary endpoints Of the events that comprised the primary efficacy endpoint, treatment with Lipitor 80 mg/day significantly reduced the rate of non-fatal, non-procedure related MI and fatal and non-fatal stroke, but not CHD death or resuscitated cardiac arrest (Table 5). Do not drive or perform other possibly unsafe tasks until you know how you react to it. Overdosage Although no specific information about Lipitor overdose is available, any medication taken in excess can have serious consequences. There are no adequate and well-controlled studies of Lipitor use during pregnancy; however in rare reports, congenital anomalies were observed following intrauterine exposure to statins. Version: 12.01. Lipitor therapy should be temporarily withheld or discontinued in any patient with an acute, serious condition suggestive of a myopathy or having a risk factor predisposing to the development of renal failure secondary to rhabdomyolysis (e.g., severe acute infection, hypotension, major surgery, trauma, severe metabolic, endocrine and electrolyte disorders, and uncontrolled seizures). You need some cholesterol for good health, but too much is not good for you. Call your doctor right away if you have unexplained muscle pain, tenderness, or weakness especially if you also have fever, unusual tiredness, and dark colored urine. They should discuss all medication, both prescription and over the counter, with their healthcare professional. Of these, 2 patients also lipitor rashes a portacaval shunt and had no significant reduction in LDL-C. A 60-year-old woman with hypercholesterolemia treated with atorvastatin developed painless horizontal diplopia, vertigo, blurry vision, elevated anti-acetylcholine receptor (anti-AchR) antibodies levels, ataxia, and paresthesia of the upper extremities. Periodic creatine phosphokinase (CPK) determinations may be considered in such situations, but there is no assurance that such monitoring will prevent the occurrence of severe myopathy. Lipitor does make its lipitor rashes into breast milk, so you should not take the drug while breastfeeding your baby. Lipitor Generic Name: atorvastatin calcium Dosage Form: tablet, film coated FULL PRESCRIBING INFORMATION Indications and Usage for Lipitor Therapy with lipid-altering agents should be only one component of multiple risk factor intervention lipitor rashes individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia. Subjects were randomly assigned to either lipitor rashes mg/day or 80 mg/day of Lipitor and followed for a median duration of 4.9 years. Most effects tended to be mild and transient. Do not start a lipitor rashes medication without telling your doctor.
Where can I get more information?
Your pharmacist can provide more information about atorvastatin.
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
Every effort lipitor rashes been made to ensure that the information provided by Cerner Multum, Inc. Following discontinuation of atorvastatin, the patient experienced significant clinical improvement with only mild residual aponeurotic ptosis after 2 months. You may also report side effects at http://www.fda.gov/medwatch. The risk of myopathy during treatment with drugs in this class is increased with concurrent administration of cyclosporine, fibric acid derivatives, erythromycin, clarithromycin, combination of ritonavir plus saquinavir or lopinavir plus ritonavir, niacin, or azole antifungals. Store at room temperature away from moisture, heat, lipitor rashes light.
See also: Lipitor dosage in more lipitor rashes happens if I miss a dose?
Take the missed dose as soon as you remember. If you would like more information, talk with your doctor. Atherosclerosis is a chronic process, and discontinuation of lipid-lowering drugs during pregnancy should have little impact on long-term outcomes of primary hypercholesterolemia therapy. Always consult your doctor or healthcare specialist for medical advice. If the tests reveal a problem, you may have to stop using the drug. Skip the missed dose if your next dose is less than 12 hours away. Do not keep medicine that is out of date or that you no longer need. Take the medicine at the lipitor rashes lipitor rashes each day.
Online pharmacy Tags
362 363 364 365 366 367 368 369 370
.
